MAPT and Alzheimer disease: Antisense oligonucleotides against GSK3β have also been tested in SAMP8 mice, which display accelerated aging along with increased Aβ levels, Tau hyperphosphorylation, neuroinflammation and cognitive deficits and have hence been used as a model of AD [177,256,257].